Brief: Embecta Q4 Revenue USD 281.9 Million
21/11/2023 10:30
Nov 21 (Reuters) - Embecta Q4 dividend USD 0.15. * Q4 net income USD 6 million * Q4 adjusted EBITDA USD 79.6 million * Q4 gross profit USD 181.8 million * Q4 adjusted operating income USD 65.2 million * Q4 adjusted gross profit USD 182.6 million * Q4 operating income USD 25.8 million
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel